Pasithea Therapeutics Statistics
Total Valuation
KTTA has a market cap or net worth of $6.69 million. The enterprise value is -$1.10 million.
Important Dates
The last earnings date was Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KTTA has 7.44 million shares outstanding. The number of shares has increased by 132.08% in one year.
Current Share Class | 7.44M |
Shares Outstanding | 7.44M |
Shares Change (YoY) | +132.08% |
Shares Change (QoQ) | +155.12% |
Owned by Insiders (%) | 1.51% |
Owned by Institutions (%) | 10.94% |
Float | 7.33M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.40 |
P/TBV Ratio | 0.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97
Current Ratio | 4.97 |
Quick Ratio | 4.16 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -85.84% and return on invested capital (ROIC) is -54.76%.
Return on Equity (ROE) | -85.84% |
Return on Assets (ROA) | -49.52% |
Return on Invested Capital (ROIC) | -54.76% |
Return on Capital Employed (ROCE) | -89.94% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.36M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.55% in the last 52 weeks. The beta is 0.26, so KTTA's price volatility has been lower than the market average.
Beta (5Y) | 0.26 |
52-Week Price Change | -81.55% |
50-Day Moving Average | 0.72 |
200-Day Moving Average | 1.53 |
Relative Strength Index (RSI) | 68.37 |
Average Volume (20 Days) | 144,073 |
Short Selling Information
The latest short interest is 32,574, so 0.44% of the outstanding shares have been sold short.
Short Interest | 32,574 |
Short Previous Month | 82,340 |
Short % of Shares Out | 0.44% |
Short % of Float | 0.44% |
Short Ratio (days to cover) | 0.31 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -13.74M |
Pretax Income | -16.28M |
Net Income | -13.46M |
EBITDA | -13.09M |
EBIT | -13.74M |
Earnings Per Share (EPS) | -$5.29 |
Full Income Statement Balance Sheet
The company has $7.22 million in cash and n/a in debt, giving a net cash position of $7.22 million or $0.97 per share.
Cash & Cash Equivalents | 7.22M |
Total Debt | n/a |
Net Cash | 7.22M |
Net Cash Per Share | $0.97 |
Equity (Book Value) | 15.18M |
Book Value Per Share | 2.04 |
Working Capital | 6.90M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -12.49M |
Capital Expenditures | n/a |
Free Cash Flow | -12.49M |
FCF Per Share | -$1.68 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |